MASP inhibitory compounds and uses thereof
US-12503491-B2 · Dec 23, 2025 · US
This page is not indexed by search engines while we improve data quality.
Holton Simon patents
Holton Simon is listed as an inventor on 47 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Holton Simon |
| Total patents | 47 |
| First publication | May 21, 2015 |
| Latest publication | Dec 23, 2025 |
Notable patents
Publications ranked by popularity score, then publication date.
Covalent PPARG inverse-agonists
US-2024150277-A1 · May 9, 2024 · US
Masp inhibitory compounds and uses thereof
US-2024124522-A1 · Apr 18, 2024 · US
Masp inhibitory compounds and uses thereof
US-2024010684-A1 · Jan 11, 2024 · US
Anti-CEACAM6 antibodies and uses thereof
US-11866495-B2 · Jan 9, 2024 · US
SUBSTITUTED 4-([1,2,4]TRIAZOLO[1,5-a]PYRIDIN-6-YL)THIOPHENE-2-CARBOXAMIDE DERIVATIVES AND USE THEREOF
US-2023382904-A1 · Nov 30, 2023 · US
Anti-CEACAM6 antibodies and uses thereof
US-11773164-B2 · Oct 3, 2023 · US
MASP inhibitory compounds and uses thereof
US-11667675-B2 · Jun 6, 2023 · US
Substituted 2-amino-pyrazolyl-[1,2,4]triazolo[1,5a]pyridine derivatives and use thereof
US-2023086702-A1 · Mar 23, 2023 · US
Masp inhibitory compounds and uses thereof
US-2021246166-A1 · Aug 12, 2021 · US
Recent patents
Latest publications not already listed above.
4-(3-amino-6-fluoro-1h-indazol-5-yl)-1,2,6-trimethyl-1,4-dihydropyridine-3,5-dic arbonitrile compounds for treating hyperproliferative disorders
US-2021047297-A1 · Feb 18, 2021 · US
Identification and use of erk5 inhibitor
US-2021017174-A1 · Jan 21, 2021 · US
Anti-ceacam6 antibodies and uses thereof
US-2020181261-A1 · Jun 11, 2020 · US
Anti-ceacam6 antibodies and uses thereof
US-2020157214-A1 · May 21, 2020 · US
Substituted benzylindazoles for use as BUB1 kinase inhibitors in the treatment of hyperproliferative diseases
US-10604532-B2 · Mar 31, 2020 · US
Anti-CEACAM6 antibodies and uses thereof
US-10584167-B2 · Mar 10, 2020 · US
3-amino-1,5,6,7-tetrahydro-4H-indol-4-ones
US-10428044-B2 · Oct 1, 2019 · US
Substituted benzylindazoles for use as bub1 kinase inhibitors in the treatment of hyperproliferative diseases
US-2019284206-A1 · Sep 19, 2019 · US
Benzyl substituted indazoles as BUB1 inhibitors
US-10350206-B2 · Jul 16, 2019 · US
Substituted benzylindazoles for use as Bub1 kinase inhibitors in the treatment of hyperproliferative diseases
US-10266548-B2 · Apr 23, 2019 · US
Anti-ceacam6 antibodies and uses thereof
US-2018162940-A1 · Jun 14, 2018 · US
Amido-substituted cyclohexane derivatives
US-2018148418-A1 · May 31, 2018 · US
2,3-benzodiazepines
US-9890147-B2 · Feb 13, 2018 · US
Amido-substituted azole compounds
US-9884063-B2 · Feb 6, 2018 · US
Benzyl substituted indazoles as bub1 kinase inhibitors
US-2017305882-A1 · Oct 26, 2017 · US
Diaminoheteroaryl substituted indazoles
US-2017283396-A1 · Oct 5, 2017 · US
Benzyl substituted indazoles as bub1 inhibitors
US-2017273980-A1 · Sep 28, 2017 · US
Substituted cycloalkenopyrazoles as bub1 inhibitors for the treatment of cancer
US-2017275267-A1 · Sep 28, 2017 · US
Heteroaryl substituted indazoles
US-2017275268-A1 · Sep 28, 2017 · US
Substituted benzylpyrazoles
US-9765058-B2 · Sep 19, 2017 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Bayer Pharma AG | 41 |
| Bayer Ag | 7 |
| Bayer Ip Gmbh | 7 |
| Schulze Volker | 2 |
| Koppitz Marcus | 2 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61P35/00 | 39 |
| A61K45/06 | 33 |
| C07D401/14 | 28 |
| A61K31/506 | 25 |
| A61P35/02 | 24 |